menu
    • menu
    [{"orgOrder":0,"company":"St. Renatus","sponsor":"Triligent International | Rho Inc","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Spray","sponsorNew":"St. Renatus \/ Triligent International | Rho Inc","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Triligent International | Rho Inc"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Triligent International | Rho Inc","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Spray","sponsorNew":"St. Renatus \/ Triligent International | Rho Inc","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Triligent International | Rho Inc"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Rho Inc | Triligent International","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Spray","sponsorNew":"St. Renatus \/ Rho Inc | Triligent International","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Rho Inc | Triligent International"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Triligent International | Rho Inc","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Spray","sponsorNew":"St. Renatus \/ Triligent International | Rho Inc","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Triligent International | Rho Inc"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Triligent International | Rho Inc | Analytical Bio-Chemistry Laboratories","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Spray","sponsorNew":"St. Renatus \/ Triligent International | Rho Inc | Analytical Bio-Chemistry Laboratories","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Triligent International | Rho Inc | Analytical Bio-Chemistry Laboratories"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Triligent International | Analytical Bio-Chemistry Laboratories | Rho Inc","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Spray","sponsorNew":"St. Renatus \/ Triligent International | Analytical Bio-Chemistry Laboratories | Rho Inc","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Triligent International | Analytical Bio-Chemistry Laboratories | Rho Inc"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Spray","sponsorNew":"St. Renatus \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Undisclosed"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Triligent International | Rho Inc","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"St. Renatus \/ Triligent International | Rho Inc","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Triligent International | Rho Inc"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Triligent International | Rho Inc","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2013","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"St. Renatus \/ Triligent International | Rho Inc","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Triligent International | Rho Inc"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Ground Zero Pharmaceuticals | Rho Inc","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"U.S.A","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Tetracaine","moa":"Sodium channel alpha subunit","graph1":"Neurology","graph2":"Phase III","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"St. Renatus \/ Ground Zero Pharmaceuticals | Rho Inc","highestDevelopmentStatusID":"10","companyTruncated":"St. Renatus \/ Ground Zero Pharmaceuticals | Rho Inc"},{"orgOrder":0,"company":"St. Renatus","sponsor":"Ground Zero Pharmaceuticals | Rho Inc","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Tetracaine Hydrochloride","moa":"Sodium channel alpha subunit","graph1":"Undisclosed","graph2":"Phase II","graph3":"St. Renatus","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"St. Renatus \/ Ground Zero Pharmaceuticals | Rho Inc","highestDevelopmentStatusID":"8","companyTruncated":"St. Renatus \/ Ground Zero Pharmaceuticals | Rho Inc"}]

    Find Clinical Drug Pipeline Developments & Deals by St. Renatus

    Menu

    St. Renatus

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Comparison of Anesthetic Efficacy of Bilateral and Unillateral Application of Kovacaine Mist in Healthy Volunt...

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            May 29, 2015

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase I

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Triligent International | Analytical Bio-Chemistry Laboratories | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety and Pharmacokinetics of Kovacaine Nasal Spray in Pediatric Subjects

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            September 30, 2013

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Triligent International | Analytical Bio-Chemistry Laboratories | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase III

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Pediatric Patients

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            May 01, 2013

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase III

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Triligent International | Rho Inc | Analytical Bio-Chemistry Laboratories

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            March 08, 2013

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Triligent International | Rho Inc | Analytical Bio-Chemistry Laboratories

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            05

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase III

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            December 10, 2012

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase III

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            06

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase III

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth in Ad...

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            October 19, 2012

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase III

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            07

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            October 05, 2012

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            08

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase III

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            August 09, 2012

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase III

                            Sponsor : Triligent International | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            09

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Rho Inc | Triligent International

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Open-Label Study of Efficacy and Recommended Dose of Kovacaine Mist for Anesthetizing Maxillary Teeth

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            November 24, 2011

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Rho Inc | Triligent International

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            10

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed

                            St. Renatus

                            U.S.A arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Study Phase : Phase II

                            Sponsor : Ground Zero Pharmaceuticals | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Dose-Escalation Safety and Pharmacokinetic Study of K305

                            Details : Tetracaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Anesthesia.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            February 25, 2011

                            Lead Product(s) : Tetracaine

                            Therapeutic Area : Neurology

                            Highest Development Status : Phase II

                            Sponsor : Ground Zero Pharmaceuticals | Rho Inc

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth